Foresters Investment Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-242,000
Closed -$12.2M 628
2017
Q3
$12.2M Buy
242,000
+2,000
+0.8% +$103K 0.2% 162
2017
Q2
$13.1M Buy
240,000
+24,000
+11% +$1.15M 0.22% 150
2017
Q1
$9.1M Buy
216,000
+48,000
+29% +$2.05M 0.16% 177
2016
Q4
$7.22M Hold
168,000
0.13% 196
2016
Q3
$6.93M Buy
168,000
+1,000
+0.6% +$41.9K 0.13% 191
2016
Q2
$6.66M Buy
167,000
+16,000
+11% +$576K 0.13% 188
2016
Q1
$5.09M Buy
151,000
+2,000
+1% +$62.3K 0.1% 203
2015
Q4
$5.05M Buy
+149,000
New +$4.66M 0.1% 200

Other funds holding IART

Foresters Investment Management's IART Position: Q4 2017 in Review

Foresters Investment Management sold out of Integra LifeSciences (IART) in Q4 2017, closing a stake of 242,000 shares — an estimated $12.2M sold.

Foresters Investment Management first reported a position in IART in Q4 2015 and held it in 8 quarters. The position peaked at $13.1M in Q2 2017. 221 funds tracked by Wall St. Rank hold IART as of Q4 2017.

  • Foresters Investment Management reported no remaining Integra LifeSciences position as of Q4 2017 after selling out during the quarter.
  • Foresters Investment Management sold 242,000 Integra LifeSciences shares in Q4 2017, an estimated $12.2M.
  • Foresters Investment Management first reported a position in Integra LifeSciences in Q4 2015 and held it in 8 quarters.
  • Foresters Investment Management's Integra LifeSciences position peaked at $13.1M in Q2 2017.
  • 221 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2017.

Based on Foresters Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.